Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net

Oncogene

Volumn 24, Issue 5, 2005, Pages 820-828

  Wasylyk, Christine ^a   Criqui Filipe, Paola ^a   Wasylyk, Bohdan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

E3 ligase; Elk 3; Erp; Sap 2; Ternary complex factor; Ubc9

Indexed keywords

LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; NET INHIBITORY DOMAIN; PROTEIN PIAS1; PROTEIN UBC9; RAS PROTEIN; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ELK 3; TRANSCRIPTION FACTOR ERP; TRANSCRIPTION FACTOR SAP 1; TRANSCRIPTION FACTOR SAP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; LYSINE; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; CERVUS ELAPHUS;

EID: 13444310577     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208226     Document Type: Article

References (43)

1. Buchwalter G, Gross C and Wasylyk B. (2004). Gene, 324, 1-14.
2. Chen C and Okayama H. (1987). Mol. Cell. Biol., 7, 2745-2752.
3. Chinnadurai G. (2002). Mol. Cell, 9, 213-224.
4. Chinnadurai G. (2003). BioEssays, 25, 9-12.
5. Criqui-Filipe P, Ducret C, Maira SM and Wasylyk B. (1999). EMBO J., 18, 3392-3403.
6. Giovane A, Pintzas A, Maira SM, Sobieszczuk P and Wasylyk B. (1994). Genes Dev., 8, 1502-1513.
7. Giovane A, Sobieszczuk P, Ayadi A, Maira SM and Wasylyk B. (1997). Mol. Cell. Biol., 17, 5667-5678.
8. Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, Snowden AW, Garcia-Wilson E, Perkins ND and Hay RT. (2003). Mol. Cell, 11, 1043-1054.
9. Gong L, Kamitani T, Fujise K, Caskey LS and Yeh ET. (1997). J. Biol. Chem., 272, 28198-28201.
10. Hahn SL, Wasylyk B, Criqui-Filipe P and Criqui P. (1997). Oncogene, 15, 1489-1495.
11. Iniguez-Lluhi JA and Pearce D. (2000). Mol. Cell. Biol., 20, 6040-6050.
12. Janknecht R and Nordheim A. (1996a). Biochem. Biophys. Res. Commun., 228, 831-837.
13. Janknecht R and Nordheim A. (1996b). Oncogene, 12, 1961-1969.
14. Johnson ES. (2004). Annu. Rev. Biochem., 73, 355-382.
15. Kagey MH, Melhuish TA and Wotton D. (2003). Cell, 113, 127-137.
16. Kim J, Cantwell CA, Johnson PF, Pfarr CM and Williams SC. (2002). J. Biol. Chem., 277, 38037-38044.
17. Kotaja N, Aittomaki S, Silvennoinen O, Palvimo JJ and Janne OA. (2000). Mol. Endocrinol., 14, 1986-2000.
18. Kotaja N, Karvonen U, Janne OA and Palvimo JJ. (2002). Mol. Cell Biol., 22, 5222-5234.
19. Le Drean Y, Mincheneau N, Le Goff P and Michel D. (2002). Endocrinology, 143, 3482-3489.
20. Lin X, Sun B, Liang M, Liang YY, Gast A, Hildebrand J, Brunicardi FC, Melchior F and Feng XH. (2003). Mol. Cell, 11, 1389-1396.
21. Long J, Matsuura I, He D, Wang G, Shuai K and Liu F. (2003). Proc. Natl. Acad. Sci. USA, 100, 9791-9796.
22. Maira SM, Wurtz JM and Wasylyk B. (1996). EMBO J., 15, 5849-5865.
23. Megidish T, Xu JH and Xu CW. (2002). J. Biol. Chem., 277, 8255-8259.
24. Melchior F, Schergaut M and Pichler A. (2003). Trends Biochem. Sci., 28, 612-618.
25. Muller S, Ledl A and Schmidt D. (2004). Oncogene, 23, 1998-2008.
26. Nishida T and Yasuda H. (2002). J. Biol. Chem., 277, 41311-41317.
27. Ross S, Best JL, Zon LI and Gill G. (2002). Mol. Cell, 10, 831-842.
28. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F and Grosschedl R. (2001). Genes Dev., 15, 3088-3103.
29. Salinas S, Briancon-Marjollet A, Bossis G, Lopez MA, Piechaczyk M, Jariel-Encontre I, Debant A and Hipskind RA. (2004). J. Cell. Biol., 165, 767-773.
30. Sampson DA, Wang M and Matunis MJ. (2001). J. Biol. Chem., 276, 21664-21669.
31. Sapetschnig A, Rischitor G, Braun H, Doll A, Schergaut M, Melchior F and Suske G. (2002). EMBO J., 21, 5206-5215.
32. Schmidt D and Muller S. (2002). Proc. Natl. Acad. Sci. USA, 99, 2872-2877.
33. Schmidt D and Muller S. (2003). Cell. Mol. Life Sci., 60, 2561-2574.
34. Seeler JS and Dejean A. (2003). Nat. Rev. Mol. Cell. Biol., 4, 690-699.
35. Sharrocks AD. (2002). Biochem. Soc. Trans., 30, 1-9.
36. Shaw PE and Saxton J. (2003). Int. J. Biochem. Cell. Biol., 35, 1210-1226.
37. Subramanian L, Benson MD and Iniguez-Lluhi JA. (2003). J. Biol. Chem., 278, 9134-9141.
38. Tan JA, Hall SH, Hamil KG, Grossman G, Petrusz P and French FS. (2002). J. Biol. Chem., 277, 16993-17001.
39. Tussie-Luna MI, Bayarsaihan D, Seto E, Ruddle FH and Roy AL. (2002). Proc. Natl. Acad. Sci. USA, 99, 12807-12812.
40. Verger A, Perdomo J and Crossley M. (2003). EMBO Rep., 4, 137-142.
41. Yang SH, Bumpass DC, Perkins ND and Sharrocks AD. (2002). Mol. Cell. Biol., 22, 5036-5046.
42. Yang SH, Jaffray E, Hay RT and Sharrocks AD. (2003a). Mol. Cell, 12, 63-74.
43. Yang SH, Sharrocks AD and Whitmarsh AJ. (2003b). Gene, 320, 3-21.